Europe Orthopedic Biomaterials Market: Product Penetration to Drive Growth

Countries covered: Europe Summary GlobalData’s “Europe Orthopedic Biomaterials Market: Market Assessment, Insight and Forecasts to 2015” report is an essential source of data and analysis on the Europe orthopedic biomaterials market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on four market categories - bone allografts, bone graft substitutes, bone growth stimulators, DBM and viscosupplementation. The report identifies the key trends shaping and driving the dynamism in the Europe orthopedic biomaterials market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the Europe orthopedic biomaterials market. Scope The report provides market size data and information on four Europe orthopedic biomaterials market categories - Bone Allografts, Bone Graft Substitutes, Bone Growth Stimulators, DBM and Viscosupplementation. Annualized market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Analysis and review of the key events and milestones that will impact the future of the Europe orthopedic biomaterials market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends. Insightful review of key industry drivers, restraints and challenges which are likely to impact the Europe orthopedic biomaterials market in the long run. In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future. The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers. Key topics covered include the M&A landscape and the impact of the economic downturn on the US insulin delivery devices market. The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts. Reasons to buy Develop business strategies by understanding the trends shaping and driving Europe orthopedic biomaterials Market. Design and develop your product development, marketing and sales strategies by identifying the market categories poised for a strong growth. Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return. Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape. Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the Europe orthopedic biomaterials market in future. Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline. Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. What’s the next being thing in the Europe orthopedic biomaterials technology landscape? - Identify, understand and capitalize.

Additional Information

A new report by GlobalData, the business intelligence specialists, finds that an increasing incidence of degenerative disc disease driven by increasing obesity and a lethargic lifestyle will drive the growth of orthopedic biomaterials in Europe. The ousting of allografts as the gold standard in the next five years is expected to place the synthetic grafts segment as the key development driving revenue growth and investor interests in the European orthopedic biomaterials sector. GlobalData’s report, “Europe Orthopedic Biomaterials: Product Penetration to Drive Growth”, highlights this as one of the key market drivers for the European orthopedic biomaterials market.

Product Approvals and Increased Acceptance to Fuel Growth in the Orthopedic Biomaterials Market
The European market for orthobiologics was valued at $644.1 million in 2001 and grew at a CAGR of 8.0% during 2001 - 2008 to reach sales of $1.1 billion in 2008. Historically the European orthobiologics market was driven by the growth of allografts as a gold standard for spinal fusion procedures and later on, with the acceptance of synthetic bone graft substitutes. The future of the European market is expected to be driven by the anticipated approval of BMP for spinal fusion and an increased awareness and acceptance of synthetic bone graft substitutes. The European market, is forecast to grow at a CAGR of 10.7% during 2008 - 2015, to reach sales of $2.2 billion in 2015.

Orthobiologics Driven by Rising Orthopedic Disease Incidence
Orthobiologic devices constitute the second largest category in the orthopedic devices market driven by a concoction of lifestyle related disorders, obesity and sports injuries. Obesity continues to be a key driver for the rising incidence of osteoarthritis around the globe. Changes in lifestyles and a sedentary work atmosphere prevailing at present for the younger population are increasing the incidences of arthritis and degenerative disc among this population group. An increasing incidence of degenerative disc disease of the lower back has led to an increase in the number of fusion procedures performed in Europe. Nearly 200,000 procedures were performed last year in the top five (France, Germany, Italy, Spain and the UK) markets of Europe. This growing incidence, coupled with an increasing use of synthetic bone graft substitutes for spinal fusions is expected to drive the growth of the orthobiologics market.

The Ousting Of Autografts and Allografts as The Gold Standard
Autologous bone graft procedures were ousted as the golden standard for orthopedic applications at the start of this decade. This was due to limitations pertaining to the mobility of the donor and due to clinical outcomes showing that the success rates of autologous bone grafts in older patients is much lower. Another problem inherent with allograft procedures is the screening of human tissues used in bone grafts and transplantations across Europe.
The European bone graft substitutes market was valued at $309.1 million in 2001. Driven by an increasing number of spinal fusion surgeries and increasing awareness of the advantages offered by synthetic bone graft substitutes over allografts, this market recorded a CAGR of 10.1% during 2001 - 2008 to reach sales of $604.9 million in 2008. The future of this segment is forecast to be driven by the anticipated approval of BMP for spinal fusion and witness a CAGR of 12.8% during 2008 - 2015 to reach sales of $1.4 billion in 2015.

More Europe Orthopedics Reports

The Medical Device Market: Hungary by Espicom Healthcare Intelligence
Espicom’s in-depth medical device market reports are ideal for executives wanting to understand the key drivers in medical markets and have access to a wealth ...

The Medical Device Market: Greece by Espicom Healthcare Intelligence
Espicom’s in-depth medical device market reports are ideal for executives wanting to understand the key drivers in medical markets and have access to a wealth ...

The Medical Device Market: Germany by Espicom Healthcare Intelligence
Espicom’s in-depth medical device market reports are ideal for executives wanting to understand the key drivers in medical markets and have access to a wealth ...

The Medical Device Market: France by Espicom Healthcare Intelligence
Espicom’s in-depth medical device market reports are ideal for executives wanting to understand the key drivers in medical markets and have access to a wealth ...

The Medical Device Market: Finland by Espicom Healthcare Intelligence
Espicom’s in-depth medical device market reports are ideal for executives wanting to understand the key drivers in medical markets and have access to a wealth ...

See all reports like this >>

More Europe Reports

A Comprehensive Study Of The UK Video Conferencing Equipment Market In 2010, Rating & Valuing Each Of The 30 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Tableware Market In 2010, Rating & Valuing Each Of The 166 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Surveyors & Valuers Market In 2010, Rating & Valuing Each Of The 943 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Subsea Engineering Market In 2010, Rating & Valuing Each Of The 142 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

A Comprehensive Study Of The UK Structural Engineering Consultancy Market In 2010, Rating & Valuing Each Of The 300 Companies That Operate In Today's Market by Plimsoll Publishing Ltd.
The Plimsoll Analysis provides you with the most up to date and comprehensive analysis of the top 9 companies operating the market. It is ...

See all reports like this >>